New cancer clinical trial: A Study of FPA144 Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer
Published on: November 15, 2017 at 10:00AM
Conditions: Gastrointestinal Cancer; Gastrointestinal Cancer Metastatic; Gastric Cancer
Intervention: Combination Product: FPA144 + mFOLFOX6
Sponsor: Five Prime Therapeutics, Inc.
Not yet recruiting
http://ift.tt/2zNwcRg
More Stories
‘My 401k Misses You’: Black Woman Pumped To Meet Donald Trump In Philadelphia – July 18, 2023 at 04:56PM
Energy Provider Warns of Impending ‘Crisis,’ ‘Blackout Conditions’ Driven By Biden Plans – July 18, 2023 at 04:20PM
Dog starts barking at cows crossing a bridge, so the cows stop to have a look. – July 17, 2023 at 02:27PM